1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

  • July 2015
  • -
  • GlobalData
  • -
  • 58 pages

Summary

Table of Contents

Search Inside

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

Summary

Genital herpes is a chronic, sexually transmitted infection caused by the herpes simplex virus (HSV) and is the primary cause of genital ulcers. Genital herpes can also be vertically transmitted from a mother to her newborn during birth, leading to a high risk of mortality in infants. HSV has two forms: HSV-1 and HSV-2. The majority of genital herpes cases globally are caused by HSV-2, although approximately half of all new cases in developed countries are caused by HSV-1. Most cases of genital herpes are asymptomatic, leading to the diagnosed prevalence being substantially lower than that of the total prevalence. The symptomatic cases of genital herpes are typically characterized by painful blisters on the genitals and surrounding areas, which normally present between four and seven days after sexual contact with another infected individual.

GlobalData epidemiologists forecast an increase in the diagnosed incident cases of genital herpes in the 7MM from 405,319 in 2013 to 448,525 diagnosed incident cases in 2023, at an Annual Growth Rate (AGR) of 1.07% during the forecast period. The distribution of diagnosed incident cases of genital herpes in the 7MM was lower in men (153,129 cases, 37.78% in 2013) than it was in women (252,190 cases, 62.22% in 2013). The diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and HSV-1 and HSV-2 co-infection genital herpes increased from 2013 to 2023 in the 7MM, with respective AGRs of 0.53%, 0.71%, and 0.74%. In all the markets, the diagnosed prevalent cases of genital herpes increased with age, which is reflective of the lifetime infection characteristic of the disease.

GlobalData’s epidemiological forecasts for the diagnosed incident cases and diagnosed prevalent cases of genital herpes are supported by age- and sex-specific data obtained from country-specific studies published in peer-reviewed journals, in which the study populations were representative of the general population in the respective markets. The forecast provides the sex-specific diagnosed incident cases of genital herpes in each of the 7MM and the diagnosed prevalent cases of genital herpes segmented by strain type (HSV-1, HSV-2, and the co-infection of HSV-1 and HSV-2), which facilitate an in-depth understanding of the epidemiological trends and informs strategies to improve the management of the disease.

Scope

- The Genital Herpes EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for genital herpes in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of genital herpes, segmented by strain (HSV-1 and HSV-2) for ages =18 years, and the diagnosed prevalent cases of HSV-1 only genital herpes, HSV-2 only genital herpes, and genital herpes caused by the co-infection of both HSV-1 and HSV-2, segmented by sex for ages =18 years.
- The Genital Herpes epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Genital Herpes EpiCast series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global genital herpes market.
- Quantify patient populations in the global genital herpes market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for genital herpes therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.